Skip to content

The clinical study of botulinum toxin A in the treatment of plantar fasciitis

A randomized, double - blind, placebo - controlled study of botulinum toxin type A in the treatment of plantar fascia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TNR-17012934
Enrollment
Unknown
Registered
2017-10-10
Start date
2017-10-09
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar fasciitis

Interventions

Control group:Placebo without any preservatives and toxin, 1 bottle

Sponsors

The Application hospital of Qingdao university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. skeletal maturity, heel pain plantar fascia is inserted at the front or at the tuberosity of the calcaneus; 2. failure of conservative treatment for 3 months, including ordinary insole and nonsteroidal anti-inflammatory drug; 3. and visual analog Table (VAS) is more than 40 mm in pain intensity; 4. plantar fascia rupture or plantar fascia more than 4 mm, and echo reduction.

Exclusion criteria

Exclusion criteria: 1. an open wound of the foot or heel, history of foot surgery or fracture; 2. Related diseases: knee or ankle dysfunction, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, Reiters syndrome; 3. Injection of plantar fasciitis in the first six months; 4. lumbal vertebra; 5. Lidocaine allergy history; 6. prior treatment with BoNT-A, existing diagnosed allergies or antibodies against BoNT-A; 7. history of chronic narcotic use for any reason; 8. a history of infection in the previous 3 months, at the application site.

Design outcomes

Primary

MeasureTime frame
VAS;FADI;AOFAS;ROM;Tenderness threshold;

Secondary

MeasureTime frame
plantar fascia thickness;Foot Infrared Thermal Imaging;Myoton;SF-36;

Contacts

Public ContactLi Tieshan

Qingdao University Hospital

tieshanl@126.com+86 18661808572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026